- Home
- YSXT vs MDXH Comparison
YSXT vs MDXH Comparison
Compare YSXT & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- MDXH
- Stock Information
- Founded
- YSXT 2011
- MDXH 2003
- Country
- YSXT China
- MDXH Belgium
- Employees
- YSXT N/A
- MDXH N/A
- Industry
- YSXT Automotive Aftermarket
- MDXH
- Sector
- YSXT Consumer Discretionary
- MDXH
- Exchange
- YSXT Nasdaq
- MDXH Nasdaq
- Market Cap
- YSXT 87.9M
- MDXH 73.3M
- IPO Year
- YSXT 2024
- MDXH 2021
- Fundamental
- Price
- YSXT $2.47
- MDXH $1.47
- Analyst Decision
- YSXT
- MDXH Buy
- Analyst Count
- YSXT 0
- MDXH 1
- Target Price
- YSXT N/A
- MDXH $6.00
- AVG Volume (30 Days)
- YSXT 8.9K
- MDXH 71.6K
- Earning Date
- YSXT 02-24-2025
- MDXH 04-30-2025
- Dividend Yield
- YSXT N/A
- MDXH N/A
- EPS Growth
- YSXT N/A
- MDXH N/A
- EPS
- YSXT 0.18
- MDXH N/A
- Revenue
- YSXT $66,143,276.00
- MDXH $90,049,000.00
- Revenue This Year
- YSXT N/A
- MDXH $23.38
- Revenue Next Year
- YSXT N/A
- MDXH $16.84
- P/E Ratio
- YSXT $13.51
- MDXH N/A
- Revenue Growth
- YSXT 21.23
- MDXH 28.29
- 52 Week Low
- YSXT $2.06
- MDXH $1.35
- 52 Week High
- YSXT $6.27
- MDXH $3.50
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- MDXH 39.40
- Support Level
- YSXT N/A
- MDXH $1.40
- Resistance Level
- YSXT N/A
- MDXH $1.56
- Average True Range (ATR)
- YSXT 0.00
- MDXH 0.08
- MACD
- YSXT 0.00
- MDXH 0.01
- Stochastic Oscillator
- YSXT 0.00
- MDXH 27.57
Stock Price Comparison Chart: YSXT vs MDXH
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.